Raptor Pharmaceutical Corp. Announces Presentation of PROCYSBI(TM) (RP103) Extension Study Data at the ASN Annual Meeting

[at noodls] – NOVATO, Calif., Oct. 17, 2012 (GLOBE NEWSWIRE) — Raptor Pharmaceutical Corp. (Raptor or the Company) (Nasdaq:RPTP), announced that Craig B. Langman, M.D., Head of Kidney Diseases, … more

View todays social media effects on RPTP

View the latest stocks trending across Twitter. Click to view dashboard